Literature DB >> 15276465

Ras, PI3-kinase and mTOR signaling in cardiac hypertrophy.

Christopher G Proud1.   

Abstract

Cardiac hypertrophy involves increased mass (growth) of the heart and a cardinal feature of this condition is increased rates of protein synthesis. Several signaling pathways have been implicated in cardiac hypertrophy including the phosphatidylinositol 3-kinase (PI3K) and Ras/Raf/MEK/Erk pathways. PI3K lies upstream of the mammalian target of rapamycin (mTOR), an important positive regulator of protein synthesis and cell growth. However, recent data suggest that, in response to certain hypertrophic agents, signaling via Ras and MEK/Erk, as well as mTOR, is required for activation of protein synthesis, indicating new connections between these key signaling pathways. Copryright 2004 European Society of Cardiology

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15276465     DOI: 10.1016/j.cardiores.2004.02.003

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  57 in total

Review 1.  Protein kinase cascades in the regulation of cardiac hypertrophy.

Authors:  Gerald W Dorn; Thomas Force
Journal:  J Clin Invest       Date:  2005-03       Impact factor: 14.808

2.  Interactions between the regulatory subunit of type I protein kinase A and p90 ribosomal S6 kinase1 regulate cardiomyocyte apoptosis.

Authors:  Xianlong Gao; Brian Lin; Sakthivel Sadayappan; Tarun B Patel
Journal:  Mol Pharmacol       Date:  2013-12-04       Impact factor: 4.436

3.  Prolonged exposure to GH impairs insulin signaling in the heart.

Authors:  J G Miquet; J F Giani; C S Martinez; M C Muñoz; L González; A I Sotelo; R K Boparai; M M Masternak; A Bartke; F P Dominici; D Turyn
Journal:  J Mol Endocrinol       Date:  2011-08-30       Impact factor: 5.098

4.  Proteomic profiling of H-Ras-G12V induced hypertrophic cardiomyopathy in transgenic mice using comparative LC-MS analysis of thin fresh-frozen tissue sections.

Authors:  Bih-Rong Wei; R Mark Simpson; Donald J Johann; Jennifer E Dwyer; Darue A Prieto; Mia Kumar; Xiaoying Ye; Brian Luke; Heather R Shive; Joshua D Webster; Shelley B Hoover; Timothy D Veenstra; Josip Blonder
Journal:  J Proteome Res       Date:  2012-02-06       Impact factor: 4.466

5.  Glycogen synthase kinase-3beta regulates post-myocardial infarction remodeling and stress-induced cardiomyocyte proliferation in vivo.

Authors:  Kathleen C Woulfe; Erhe Gao; Hind Lal; David Harris; Qian Fan; Ronald Vagnozzi; Morgan DeCaul; Xiying Shang; Satish Patel; James R Woodgett; Thomas Force; Jibin Zhou
Journal:  Circ Res       Date:  2010-04-01       Impact factor: 17.367

Review 6.  Cardioprotective signaling by endothelin.

Authors:  Anita Schorlemmer; Michelle L Matter; Ralph V Shohet
Journal:  Trends Cardiovasc Med       Date:  2008-10       Impact factor: 6.677

Review 7.  The mTOR Signaling Pathway in Myocardial Dysfunction in Type 2 Diabetes Mellitus.

Authors:  Tomohiro Suhara; Yuichi Baba; Briana K Shimada; Jason K Higa; Takashi Matsui
Journal:  Curr Diab Rep       Date:  2017-06       Impact factor: 4.810

8.  A cardiac-enriched microRNA, miR-378, blocks cardiac hypertrophy by targeting Ras signaling.

Authors:  Raghu S Nagalingam; Nagalingam R Sundaresan; Mahesh P Gupta; David L Geenen; R John Solaro; Madhu Gupta
Journal:  J Biol Chem       Date:  2013-02-27       Impact factor: 5.157

9.  Cardiomyocyte-specific loss of neurofibromin promotes cardiac hypertrophy and dysfunction.

Authors:  Junwang Xu; Fraz A Ismat; Tao Wang; Min Min Lu; Nicole Antonucci; Jonathan A Epstein
Journal:  Circ Res       Date:  2009-07-02       Impact factor: 17.367

10.  Translation inhibition reveals interaction of 2'-deoxy and 2'-O-methyl molecular beacons with mRNA targets in living cells.

Authors:  Nitin Nitin; Won Jong Rhee; Gang Bao
Journal:  Nucleic Acids Res       Date:  2009-06-15       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.